Extended stability of oxytocin in common infusion solutions

International Journal of Pharmaceutical Compounding

Volumn 10, Issue 2, 2006, Pages 156-158

  Trissel, Lawrence A ^a   Zhang, Yanping ^a   Douglass, Kate ^b   Kastango, Eric ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SoluNet LLC   (United States)

^c Clinical IQ LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; OXYTOCIN; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ARTICLE; DRUG DECOMPOSITION; DRUG ELIMINATION; DRUG STABILITY; FLUORESCENT LIGHTING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFUSION; PRECIPITATION; ROOM TEMPERATURE; TURBIDIMETRY;

EID: 33644935999     PISSN: 10924221     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. McEvoy GK, ed. AHFS Drug Information-2005. Bethesda, MD: American Society of Health-System Pharmacists; 2005: 3149.
2. Trissel LA. Handbook on Injectable Drugs. 13th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2004: 1151.
3. Gard JW, Alexander JM, Bawdon RE et al. Oxytocin preparation stability in several common obstetric intravenous solutions. Am J Obstet Gynecol 2002; 186(3): 496-498.
4. Trissel LA, Bready BB. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Am J Hosp Pharm 1992; 49(7): 1716-1719.
5. Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm 1993; 50(2): 300-304.
6. Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993; 50(11): 2359-2363.
7. United States Pharmacopeial Convention, Inc. United States Pharmacopeia 28-National Formulary 23. Rockville, MD: US Pharmacopeial Convention, Inc.; 2004: 1455.